Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00428662
Status:
UNKNOWN
Last Update Posted:
2007-01-30
First Post:
2007-01-29
Brief Title:
Evaluation of a New Nanotechnology Based Drug-Eluting Stent for Opening of Narrowed Arteries of the Heart
Sponsor:
All India Institute of Medical Sciences New Delhi
Organization:
All India Institute of Medical Sciences New Delhi
Study Overview
Official Title:
Clinical and Angiographic Evaluation of Paclitaxel Eluting Non-Polymeric Nanoporous Carbon-Carbon Coated Cobalt-Chromium Stent
Status:
UNKNOWN
Status Verified Date:
2007-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Coronary artery disease CAD is the largest cause of death and disability in the world Besides medicines the principle treatment of this condition requires opening of the narrowed arteries responsible for angina and other symptoms of the disease by angioplasty or surgery Introduction of metal scaffolds called stents in the past few decades revolutionised the angioplasty technique and has made it the most popular treatment today for CAD However these stents are prone to becomin narrow and obstructed after implanataion causing symptoms and non-fatal heart attacks in some patients Introduction of stents that slowly release drugs locally to minimize this process called drug-eluting stentsDEShe past few years has been one of the biggest breakthroughs in the field of cardiology However ven the current available DES are still prone to narrowing in high-risk patients like those with diabetes and also have a higher chance for sudden blockage by a blood clot even many years later after insertion Thus it is important to develop technology for more efficacious and safer DESThis includes safer drugs better stent design and delivery and more inert platforms for drug release We hypothesise that a new stent made with nanoporous particle with better polymer for drug release will prove to be safer and more efficacious alternative to currently available DES
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None